Pierrel S.p.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
29,185.00
15,106.00
16,149.00
14,516.00
17,303.00
Cost of Goods Sold (COGS) incl. D&A
34,708.00
15,723.00
14,738.00
13,305.00
12,198.00
Gross Income
5,523.00
617.00
1,411.00
1,211.00
5,105.00
SG&A Expense
6,911.00
2,607.00
3,193.00
3,134.00
3,814.00
EBIT
13,418.00
-
-
1,705.00
1,073.00
Unusual Expense
7.00
-
54.00
3,266.00
1,092.00
Non Operating Income/Expense
1,564.00
137.00
193.00
590.00
10.00
Interest Expense
1,034.00
3,053.00
2,584.00
1,876.00
3,391.00
Pretax Income
15,751.00
6,690.00
5,172.00
7,436.00
2,267.00
Income Tax
100.00
198.00
630.00
25.00
249.00
Consolidated Net Income
15,651.00
6,888.00
5,802.00
7,411.00
2,516.00
Net Income
12,952.00
2,409.00
151.00
6,188.00
2,516.00
Net Income After Extraordinaries
12,952.00
8,825.00
7,882.00
14,735.00
2,516.00
Net Income Available to Common
12,952.00
13,643.00
7,580.00
2,359.00
2,516.00
EPS (Basic)
0.24
0.26
0.13
0.04
0.05
Basic Shares Outstanding
53,734.10
53,734.10
57,448.70
59,067.00
59,067.00
EPS (Diluted)
0.24
0.25
0.13
0.04
0.04
Diluted Shares Outstanding
53,734.10
53,734.10
57,448.70
59,067.00
59,067.00
EBITDA
9,512.00
795.00
319.00
497.00
2,140.00
Other Operating Expense
984.00
284.00
564.00
218.00
218.00
Non-Operating Interest Income
258.00
8.00
5.00
1.00
1,153.00
Minority Interest Expense
2,699.00
4,479.00
5,953.00
1,223.00
-

About Pierrel

View Profile
Address
Strada Statale Appia 7-bis 46/48
Capua Caserta 81043
Italy
Employees -
Website http://www.pierrelgroup.com
Updated 09/14/2018
Pierrel SpA engages in the clinical research of medicinal product candidates. It operates through the following business divisions: Tech-driven Contract Research & Development Organization (TCRDO), Contract Manufacturing, and Pharma. The TCRDO division focuses on the repositioning of existing drugs in new indications.